FDA Inspection 1218003 — The Sperm And Embryo Bank Of New Jersey, Inc.

The Sperm And Embryo Bank Of New Jersey, Inc. — FEI 3003945123

The FDA completed an inspection of The Sperm And Embryo Bank Of New Jersey, Inc. on Sep 5, 2023 in Mountainside, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 5, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mountainside, NJ (United States)

Citations

IDCFRDescription
1223021 CFR 1271.50(a)Responsible person to determine, document
1228621 CFR 1271.80(b)Specimen collections not timely
1502621 CFR 1271.85(c)Reproductive cells or tissues-cell-associated CD

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.